Breccia, M. http://orcid.org/0000-0003-1163-6162
Piciocchi, A.
Messina, M. http://orcid.org/0000-0003-3531-4766
Soddu, S.
De Stefano, V.
Bellini, M.
Iurlo, A.
Martino, B.
Siragusa, S.
Albano, F.
Mora, B.
Fazi, P.
Vignetti, M.
Guglielmelli, P. http://orcid.org/0000-0003-1809-284X
Palandri, F. http://orcid.org/0000-0001-8367-5668
Article History
Received: 2 June 2022
Revised: 27 July 2022
Accepted: 1 August 2022
First Online: 13 August 2022
Competing interests
: MB received honoraria by Novartis, Pfizer, Incyte, BMS. FP received honoraria by Novartis, Celgene, AOP, Sierra Oncology and CTI. VDS received grants from Amgen, Celgene, Novartis.
Free to read: This content has been made available to all.